ADHD, the most common neurodevelopmental disorder, affects around 5% of children, with many continuing to experience symptoms into adulthood, complicating daily life.
Because of a lack of investment in adult-specific clinical trials, many adults receiving treatment for ADHD rely on off-label use of medications that are effective in children.
The recent Lancet Psychiatry analysis emphasized that stimulants remain the only effective interventions for adult ADHD in the short term, though they differ in tolerability.
Narcis Cardoner highlights the absurdity of adults needing off-label treatments for ADHD medications that are effective but not officially approved for their use.
Collection
[
|
...
]